Human Umbilical Cord Mesenchymal Stem Cells is named as a drug or biological intervention in 3 clinical trials in our China and USA trial registers, 1 of which is recruiting. Lead sponsors include MED Institute Inc. (1), BOE Technology Group Co., Ltd. (1) and Shanghai IxCell Biotechnology Co., LTD (1). Registered phases: Phase 2, Phase 1 and Phase 3. Conditions studied include Duchenne Muscular Dystrophy; Acute Ischemic Stroke; AIS.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06716281 | Efficacy and Safety of IxCell hUC-MSC-O in Patients With Knee Osteoarthritis (ClinicalTrials.gov ↗) Knee Osteoarthritis |
Phase 3 | Recruiting |
| NCT07628933 | A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke (ClinicalTrials.gov ↗) Acute Ischemic Stroke, AIS |
Phase 1 | Not yet open |
| NCT06579352 | Study of UC-MSC in DMD Patients (ClinicalTrials.gov ↗) Duchenne Muscular Dystrophy |
Phase 2 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Duchenne Muscular Dystrophy | 1 |
| Acute Ischemic Stroke | 1 |
| AIS | 1 |
| Knee Osteoarthritis | 1 |
| Lead sponsor | Trials |
|---|---|
| MED Institute Inc. | 1 |
| BOE Technology Group Co., Ltd. | 1 |
| Shanghai IxCell Biotechnology Co., LTD | 1 |
| Register | Human Umbilical Cord Mesenchymal Stem Cells trials |
|---|---|
| Clinical trials in China | 2 |
| Clinical trials in USA | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Human Umbilical Cord Mesenchymal Stem Cells works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Human Umbilical Cord Mesenchymal Stem Cells (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.